Pharmexcil, the Pharmaceutical Export Promotion Council of India, is advocating for the alignment of Goods and Services Tax (GST) rates within the pharmaceutical industry to streamline compliance processes and address the existing inverted duty structure. At present, there is a notable tax gap between active pharmaceutical ingredients (APIs) and formulations, leading to inefficiencies within the industry and increased operational costs. The proposed reforms aim to establish tax parity between these two components, ultimately benefiting the healthcare ecosystem and patients by ensuring affordability and improved revenue maintenance.
Currently, formulations, which refer to finished medicines, are subjected to a GST rate of 12%, while APIs face a higher tax rate of 18%. Bhavin Mehta, the Vice Chairman of Pharmexcil, has highlighted the potential consequences if formulations were to shift to a lower tax bracket of 5% while APIs remained at 18%. This scenario would exacerbate the existing inverted duty structure, widening the gap from 6% to 13%. Mehta emphasizes that aligning the GST rates for APIs and formulations is crucial to address this issue, suggesting either setting both at 5% for increased affordability or at 12% to maintain revenue levels.
In addition to advocating for GST rate alignment, Mehta has emphasized the importance of implementing reforms that specifically cater to micro, small, and medium enterprises (MSMEs) within the pharmaceutical sector. He proposes the establishment of a fast-track refund system with strict timelines and interim support measures to alleviate the compliance burden on these entities. Furthermore, Mehta points out a significant issue where hospitals and diagnostic centers, which are currently exempt from GST, are unable to reclaim input taxes on consumables, leading to inflated costs for patients. By addressing these discrepancies through comprehensive reforms, the efficiency of the healthcare system can be significantly enhanced.
The call for GST rate alignment within the pharmaceutical industry is not only aimed at simplifying compliance processes and rectifying the inverted duty structure but also at fostering a more competitive and sustainable ecosystem. By ensuring tax parity between APIs and formulations, the industry can operate more effectively, reduce operational costs, and enhance overall revenue maintenance. Moreover, aligning GST rates will contribute to improving affordability of essential medicines for patients, ultimately benefiting the healthcare sector as a whole. Pharmexcil’s advocacy for these reforms underscores the importance of regulatory alignment and support for the growth and development of the pharmaceutical industry in India.
Takeaways:
– Alignment of GST rates between active pharmaceutical ingredients and formulations is crucial for industry efficiency and cost management.
– Reforms to support micro, small, and medium enterprises within the pharmaceutical sector are essential for compliance and operational sustainability.
– Addressing discrepancies in GST exemptions for hospitals and diagnostic centers can lead to reduced patient costs and enhanced efficiency in the healthcare system.
Read more on devdiscourse.com